Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Rev. esp. enferm. dig ; 115(12): 724-725, Dic. 2023. ilus
Artículo en Inglés | IBECS | ID: ibc-228715

RESUMEN

We are writing to make endoscopists aware of the paramount of a prompt diagnosis of gastrointestinal Kaposi sarcoma (GI-KS). Patients with GI involvement have a two to five times higher risk of death and will benefit from chemotherapy to improve their survival. However, current evidence found that one out of three patients might have a false negative result even with HHV-8 since other entities such as gastrointestinal stromal tumors, angiosarcoma, and lymphoma shared macroscopic and histopathological characteristics. These cause a delay in treatment and significantly worsen the prognosis. We observed a trend for a positive diagnosis from ulcers and nodules. To our knowledge, this is the largest cohort of patients with GI-KS in the world. Our study suggests that in cases where a complete immunochemistry panel for KS is not available, HHV-8 remains as a bare minimum. However, other gastrointestinal lesions shared histopathological characteristics. Therefore, we suggest taking biopsies from nodular and ulcer-type lesions to increase the probability to establish a histopathological diagnosis.(AU)


Asunto(s)
Humanos , Sarcoma de Kaposi/diagnóstico , Herpesvirus Humano 8 , Endoscopía Gastrointestinal , Tumores del Estroma Gastrointestinal , Hematoxilina/administración & dosificación , Eosina Amarillenta-(YS)/administración & dosificación , Enfermedades Gastrointestinales , Pacientes Internos , Examen Físico
2.
Pan Afr Med J ; 39: 63, 2021.
Artículo en Francés | MEDLINE | ID: mdl-34422186

RESUMEN

Primary surgical closure for the treatment of giant omphalocele is punctuated by the onset of unpleasant complications. Conservative treatment is an option in low-income countries where neonatal resuscitation is associated with high mortality rates. We conducted a prospective study of patients admitted to the University Clinics of Lubumbashi between January and April 2020 and receiving conservative treatment based on dissodic 2% aqueous eosin according to a defined protocol. Three patients were included in our series. The mean age was 24 hours (1 - 48); they were all full term newborns (38 - 39 SA), born vaginally and with no prenatal diagnosis. Mean birth weight was 2,800 grams (2,400 - 3,000). Mean amniotic sac diameter was 13.7 cm (11 - 15 cm); it contained the liver in all cases. The median time to enteral feed was 4.3 days (4 - 5 days), to granulation was 31.7 days (30 - 33 days) and to epithelialization was 71.7 days (60 - 90 days). No death was reported. These preliminary results encourage the use of disodium aqueous eosin for the conservative treatment of unbroken giant omphaloceles.


Asunto(s)
Tratamiento Conservador/métodos , Eosina Amarillenta-(YS)/administración & dosificación , Hernia Umbilical/tratamiento farmacológico , Femenino , Hernia Umbilical/diagnóstico , Humanos , Recién Nacido , Masculino , Embarazo , Estudios Prospectivos
3.
J Vasc Access ; 21(6): 945-952, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32364801

RESUMEN

BACKGROUND: Administering a separator fluid between incompatible solutions can optimize the use of intravenous lumens. Factors affecting the required separator fluid volume to safely separate incompatible solutions are unknown. METHODS: An intravenous tube (2-m, 2-mL, 6-French) containing methylene blue dye was flushed with separator fluid until a methylene blue concentration ⩽2% from initial was reached. Independent variables were administration rate, dye solvent (glucose 5% and NaCl 0.9%), and separator fluid. In the second part of the study, methylene blue, separator fluid, and eosin yellow were administered in various administration profiles using 2- and 4-mL (2 × 2 m, 4-mL, 6-French) intravenous tubes. RESULTS: Neither administration rate nor solvent affected the separator fluid volume (p = 0.24 and p = 0.12, respectively). Glucose 5% as separator fluid required a marginally smaller mean ± SD separator fluid volume than NaCl 0.9% (3.64 ± 0.13 mL vs 3.82 ± 0.11 mL, p < 0.001). Using 2-mL tubing required less separator fluid volume than 4-mL tubing for methylene blue (3.89 ± 0.57 mL vs 4.91 ± 0.88 mL, p = 0.01) and eosin yellow (4.41 ± 0.56 mL vs 5.63 ± 0.15 mL, p < 0.001). Extended tubing required less separator fluid volume/mL of tubing than smaller tubing for both methylene blue (2 vs 4 mL, 1.54 ± 0.22 vs 1.10 ± 0.19, p < 0.001) and eosin yellow (2 vs 4 mL, 1.75 ± 0.22 vs 1.25 ± 0.03, p < 0.001). CONCLUSION: The separator fluid volume was neither affected by the administration rate nor by solvent. Glucose 5% required a marginally smaller separator fluid volume than NaCl 0.9%, however its clinical impact is debatable. A larger intravenous tubing volume requires a larger separator fluid volume. However, the ratio of separator fluid volume to the tubing's volume decreases as the tubing volume increases.


Asunto(s)
Sistemas de Liberación de Medicamentos/instrumentación , Eosina Amarillenta-(YS)/administración & dosificación , Bombas de Infusión , Azul de Metileno/administración & dosificación , Diseño de Equipo , Glucosa/administración & dosificación , Infusiones Intravenosas , Ensayo de Materiales , Cloruro de Sodio/administración & dosificación , Solventes/administración & dosificación , Factores de Tiempo
4.
Skin Pharmacol Physiol ; 33(6): 323-330, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33494089

RESUMEN

BACKGROUND: With the increasing diffusion of tattooing, the photolability of tattoo inks has become a critical issue, as available data indicated that several tattoo colorants are unstable under sunlight, generating potentially toxic photodegradation products. Therefore, it is desirable to enhance the photostability of coloring agents contained in tattoo inks. AIMS: Lipid microparticles (LMs) highly loaded with Acid Red 87 (C.I. 45380), a colorant used in tattoo inks, were evaluated for their effect on the colorant photoinstability. In addition, the capacity of the LMs to retain the incorporated C.I. 45380 colorant after their intradermal administration in excised porcine skin was investigated. METHODS: LMs loaded with C.I. 45380 were prepared using glyceryl tristearate as the lipidic material and phosphatidylcholine as the surfactant. Non-encapsulated C.I. 45380 or the colorant-loaded LMs were irradiated with a solar simulator for photodecomposition studies or introduced in the excised porcine skin mounted in Franz diffusion cells for stability evaluation in the dermal tissue. RESULTS AND CONCLUSION: The colorant content of the microparticles was 17.7%, and their size ranged from 25 to 170 µm. The light-induced degradation of C.I. 45380 was significantly decreased by its incorporation in the LMs from 20.2 ± 5.8% to 1.9 ± 2.1%. Moreover, after intradermal injection of free or microencapsulated C.I. 45380 in the excised pig skin, the LMs reduced by 93.7% (from 24.6 to 1.5%) the quantity of the colorant diffused and hence lost in the Franz cell receptor fluid. Hence, the LM carrier efficiently retained the entrapped C.I. 45380 following incubation in the dermal region of the isolated porcine skin, which is in favor of a long-lasting tattoo. Based on these data, the incorporation of C.I. 45380 in the LMs could represent a potentially useful strategy to reduce the photodecomposition of the tattoo colorant and its harmful interactions with the skin tissue.


Asunto(s)
Eosina Amarillenta-(YS)/farmacocinética , Colorantes Fluorescentes/farmacocinética , Absorción Cutánea/efectos de los fármacos , Piel/metabolismo , Tatuaje/métodos , Triglicéridos/química , Animales , Eosina Amarillenta-(YS)/administración & dosificación , Eosina Amarillenta-(YS)/química , Eosina Amarillenta-(YS)/efectos de la radiación , Colorantes Fluorescentes/administración & dosificación , Colorantes Fluorescentes/química , Colorantes Fluorescentes/efectos de la radiación , Lípidos/química , Fotólisis , Piel/efectos de los fármacos , Piel/efectos de la radiación , Absorción Cutánea/efectos de la radiación , Luz Solar/efectos adversos , Porcinos
5.
Eur J Pharm Biopharm ; 130: 71-82, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29928979

RESUMEN

Emulsions are known to be effective carriers of hydrophobic drugs, and particularly injectable emulsions have been successfully implemented for in vivo controlled drug release. Recently, high internal phase emulsions have also been used to produce porous polymeric templates for pharmaceutical applications. However, emulsions containing dissolved biopolymers both in the oil and water phases are very scarce. In this study, we demonstrate such an emulsion, in which the oil phase contains a hydrophobic biodegradable polymer, MaterBi®, and the water phase is aqueous sodium alginate dispersion. The two phases were emulsified simply by ultrasonic processing without any surfactants. The emulsions were stable for several days and were dried into composite solid films with varying MaterBi®/alginate fractions. The films were loaded with two model drugs, a hydrophilic eosin-based cutaneous antiseptic and the hydrophobic curcumin. Drug release capacity of the films was investigated in detail, and controlled release of each model drug was achieved either by tuning the polymer fraction in the films during emulsification or by crosslinking sodium alginate fraction of the films by calcium salt solution immersion. The emulsions can be formulated to carry either a single model drug or both drugs depending on the desired application. Films demonstrate excellent cell biocompatibility against human dermal fibroblast, adult cells.


Asunto(s)
Alginatos/química , Curcumina/administración & dosificación , Eosina Amarillenta-(YS)/administración & dosificación , Polímeros/química , Adulto , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/química , Reactivos de Enlaces Cruzados/química , Curcumina/química , Preparaciones de Acción Retardada , Sistemas de Liberación de Medicamentos , Liberación de Fármacos , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Emulsiones , Eosina Amarillenta-(YS)/química , Fibroblastos/metabolismo , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Porosidad , Tensoactivos/química , Factores de Tiempo , Agua/química
6.
Sci Rep ; 8(1): 3395, 2018 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-29467373

RESUMEN

Image-based machine learning and deep learning in particular has recently shown expert-level accuracy in medical image classification. In this study, we combine convolutional and recurrent architectures to train a deep network to predict colorectal cancer outcome based on images of tumour tissue samples. The novelty of our approach is that we directly predict patient outcome, without any intermediate tissue classification. We evaluate a set of digitized haematoxylin-eosin-stained tumour tissue microarray (TMA) samples from 420 colorectal cancer patients with clinicopathological and outcome data available. The results show that deep learning-based outcome prediction with only small tissue areas as input outperforms (hazard ratio 2.3; CI 95% 1.79-3.03; AUC 0.69) visual histological assessment performed by human experts on both TMA spot (HR 1.67; CI 95% 1.28-2.19; AUC 0.58) and whole-slide level (HR 1.65; CI 95% 1.30-2.15; AUC 0.57) in the stratification into low- and high-risk patients. Our results suggest that state-of-the-art deep learning techniques can extract more prognostic information from the tissue morphology of colorectal cancer than an experienced human observer.


Asunto(s)
Neoplasias Colorrectales/patología , Anciano , Algoritmos , Aprendizaje Profundo , Eosina Amarillenta-(YS)/administración & dosificación , Femenino , Hematoxilina/administración & dosificación , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Aprendizaje Automático , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos
7.
Cytometry A ; 91(8): 785-793, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28727286

RESUMEN

Currently, diagnosis of colon cancer is based on manual examination of histopathological images by a pathologist. This can be time consuming and interpretation of the images is subject to inter- and intra-observer variability. This may be improved by introducing a computer-aided diagnosis (CAD) system for automatic detection of cancer tissue within whole slide hematoxylin and eosin (H&E) stains. Cancer disrupts the normal control mechanisms of cell proliferation and differentiation, affecting the structure and appearance of the cells. Therefore, extracting features from segmented cell nuclei structures may provide useful information to detect cancer tissue. A framework for automatic classification of regions of interest (ROI) containing either benign or cancerous colon tissue extracted from whole slide H&E stained images using cell nuclei features was proposed. A total of 1,596 ROI's were extracted from 87 whole slide H&E stains (44 benign and 43 cancer). A cell nuclei segmentation algorithm consisting of color deconvolution, k-means clustering, local adaptive thresholding, and cell separation was performed within the ROI's to extract cell nuclei features. From the segmented cell nuclei structures a total of 750 texture and intensity-based features were extracted for classification of the ROI's. The nine most discriminative cell nuclei features were used in a random forest classifier to determine if the ROI's contained benign or cancer tissue. The ROI classification obtained an area under the curve (AUC) of 0.96, sensitivity of 0.88, specificity of 0.92, and accuracy of 0.91 using an optimized threshold. The developed framework showed promising results in using cell nuclei features to classify ROIs into containing benign or cancer tissue in H&E stained tissue samples. © 2017 International Society for Advancement of Cytometry.


Asunto(s)
Núcleo Celular/patología , Neoplasias del Colon/patología , Eosina Amarillenta-(YS)/administración & dosificación , Hematoxilina/administración & dosificación , Algoritmos , Área Bajo la Curva , Humanos , Interpretación de Imagen Asistida por Computador/métodos , Sensibilidad y Especificidad , Coloración y Etiquetado/métodos
8.
Afr J Paediatr Surg ; 11(2): 170-3, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24841021

RESUMEN

BACKGROUND: The surgical management of giant omphalocele is a surgical challenge with high mortality and morbidity in our country due to the absence of neonatal resuscitation. This study evaluates conservative management of giant omphalocele with dissodic 2% aqueous eosin. MATERIALS AND METHODS: In the period from January 1997 to December 2012, giant omphaloceles were treated with dissodic 2% aqueous eosin. The procedure consisted of twice a day application of dissodic 2% aqueous eosin (sterile solution for topical application) on the omphalocele sac. The procedure was taught to the mother to continue at home with an outpatient follow-up to assess epithelialization. We studied the duration of the hospital stay, the learning curve of the procedure by the mother, the complications, the duration and the percentage of complete epithelialization and the mortality. RESULTS: A total of 173 giant omphaloceles had a conservative treatment with dissodic 2% aqueous eosin. The average hospital stay was 21 ± 6 days. The learning curve by the mother of the procedure was 10 ± 3 days. Complications of treatment were intestinal functional occlusion 22% and omphalocele sac infection 18%. The complete epithelialization of the omphaloceles sac after application of dissodic 2% aqueous eosin was 68.5%. Mortality was observed in 25.5%. CONCLUSION: Conservative treatment of giant omphaloceles by dissodic 2% aqueous eosin is a simple, efficient and a good alternative to surgery. The mother can easily learn its procedure which reduces the duration of hospital stay.


Asunto(s)
Eosina Amarillenta-(YS)/administración & dosificación , Hernia Umbilical/diagnóstico , Hernia Umbilical/tratamiento farmacológico , Estudios de Cohortes , Côte d'Ivoire , Femenino , Estudios de Seguimiento , Humanos , Recién Nacido , Inyecciones Intralesiones , Tiempo de Internación , Masculino , Seguridad del Paciente , Estudios Retrospectivos , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
9.
Photodiagnosis Photodyn Ther ; 10(2): 134-40, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23769279

RESUMEN

In dentistry, residual infection remains a major cause of failure after endodontic treatment; many of these infections involve Enterococcus faecalis. In the current study, we explored the possibility that blue light activated photosensitizers could be used, in principle, to inactivate this microbe as an adjunct disinfection strategy for endodontic therapy. Three blue light absorbing photosensitizers, eosin-Y, rose bengal, and curcumin, were tested on E. faecalis grown in planktonic suspensions or biofilms. Photosensitizers were incubated for 30 min with bacteria then exposed to blue light (450-500 nm) for 240 s. Sodium hypochlorite (3%) was used as a control. After 48 h, the viability of E. faecalis was estimated by measuring colony-forming units post-exposure vs. untreated controls (CFU/mL). Blue light irradiation alone did not alter E. faecalis viability. For planktonic cultures, blue light activated eosin-Y (5 µM), rose bengal (1 µM), or curcumin (5 µM) significantly (p<0.05) reduced E. faecalis viability compared to exposure to the unirradiated photochemicals. For biofilm cultures, concentrations of light-activated eosin-Y, rose bengal, and curcumin of 100, 10, and 10 µM respectively, completely suppressed E. faecalis viability (p<0.05). Although the current results are limited to an in vitro model, they support further exploration of blue light activated antimicrobials as an adjunct therapy in endodontic treatment.


Asunto(s)
Curcumina/administración & dosificación , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/efectos de la radiación , Eosina Amarillenta-(YS)/administración & dosificación , Iluminación/métodos , Fotoquimioterapia/métodos , Rosa Bengala/administración & dosificación , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/efectos de la radiación , Color , Relación Dosis-Respuesta a Droga , Relación Dosis-Respuesta en la Radiación , Enterococcus faecalis/citología , Colorantes Fluorescentes/administración & dosificación , Viabilidad Microbiana/efectos de los fármacos , Viabilidad Microbiana/efectos de la radiación , Fármacos Fotosensibilizantes/administración & dosificación
10.
Neurosci Res ; 66(4): 412-4, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20060427

RESUMEN

The relative effects of multiple drugs give an important clue to dissect a neuronal mechanism and to seek for a candidate neurotherapeutical agent. Here we have devised a "flute" applicator which can deliver several drugs to a neural cell preparation. The applicator stands by, cleaning itself with bath perfusate and delivers drugs only during test applications. This minimizes drug cross-talk in and leakage from the applicator and drug consumption. Using the applicator, we successfully compared the relative effects of widely different doses of an agonist in single neurons. The flute applicator would be a useful tool for pharmacological analyses.


Asunto(s)
Evaluación Preclínica de Medicamentos/instrumentación , Preparaciones Farmacéuticas/administración & dosificación , Animales , Células Cultivadas , Eosina Amarillenta-(YS)/administración & dosificación , Falla de Equipo , Colorantes Fluorescentes/administración & dosificación , Glicina/administración & dosificación , Glicina/análogos & derivados , Glicina/farmacología , Técnicas In Vitro , Isoquinolinas/administración & dosificación , Ratones , Técnicas de Placa-Clamp , Farmacología , Células de Purkinje/efectos de los fármacos , Células de Purkinje/fisiología , Receptores de Glutamato Metabotrópico/agonistas , Resorcinoles/administración & dosificación , Resorcinoles/farmacología
11.
Cancer Radiother ; 13(4): 259-66, 2009 Jul.
Artículo en Francés | MEDLINE | ID: mdl-19524470

RESUMEN

Radio-epithelitis represents a common problem, for which treatments are characterized by a great heterogeneity. The present review of literature focuses on data referenced in Pubmed((c))/Medline((c)) and published in French/English. Despite a real preclinical rationale, aloe vera and trolamine failed to demonstrate any benefit in the prophylactic settings. In a prospective assessment phase III assessment, Calendula Officinalis was shown to be superior to trolamine for the prevention of radio-epithelitis. In the curative settings, sucrafalte failed to demonstrate any benefit. The benefit of dermocorticoids was suggested in terms of erythema and itching. Promising clinical results are available with hyaluronic acid (MA S065D and Ialugen) and silver leaf may reduce the intensity of cutaneous radio-induced side effects. Data from the literature are conflicting, making real the difficulty to adopt from clinical trials any proof-of-principle strategy. Considering these uncertainties, several strategies are allowed. New topics are under investigation. Present data from the literature highlight the need for further trials, in order to propose evidence-based treatments and to harmonize clinical practice.


Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Fitoterapia , Preparaciones de Plantas/administración & dosificación , Radiodermatitis/prevención & control , Radioterapia/efectos adversos , Administración Tópica , Corticoesteroides/administración & dosificación , Aloe , Calendula , Emulsiones , Eosina Amarillenta-(YS)/administración & dosificación , Ácidos Grasos/administración & dosificación , Humanos , Ácido Hialurónico/administración & dosificación , Lípidos/administración & dosificación , Radiodermatitis/terapia , Salicilatos/administración & dosificación , Sesquiterpenos/administración & dosificación , Sucralfato/administración & dosificación
13.
Int J Immunopathol Pharmacol ; 22(4): 1067-75, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20074471

RESUMEN

Psoriasis is a multifactorial skin dermatosis characterized in its classical form by erythematous and hyperkeratotic plaques on extensor surfaces of the body, that in most cases can be managed therapeutically by topical agents. Hyperproliferation and a marked inflammation in both epidermis and dermis are thought to be driven by interaction of activated type-1 T lymphocytes and antigen-presenting cells and keratinocytes that release several proinflammatory and immunomodulating molecules. The aim of this study is to investigate whether tetrabromofluorecin, commonly know as eosin, a classical compound traditionally topically used in psoriasis for its presumed anti-inflammatory activities, is able to modulate the production of TNF-alpha, IL-6 and IL-8 that are recognized as the most active and characterized cytokines in the pathogenesis of this skin disorder. HaCaT cell line was used to verify the effects on epidermal inflammation by eosin at scalar doses after testing the viability of cells. Two different population of cells, one stimulated by IFNgamma and one non-stimulated, were cultivated in presence of tolerable concentrations. The expression and release of IL-6, IL-8, IL-10, and TNF-alpha were analysed by RT-PCR and ELISA, respectively. Our results show that tolerable concentrations of eosin were 0.05%, 0.02%, and 0.01%. The expression and production of TNFalpha, IL-8 and IL-6 were dramatically reduced in presence of eosin 0.05% and 0.02% and the action of eosin was more pronounced on TNF-alpha. In agreement with clinical data, our results show that in presence of tolerable concentrations, eosin seems to influence remarkably the production of three important cytokines involved in the hyperproliferation and inflammatory process, giving a specific explanation of its efficacy and supporting its topical use in the clinical setting.


Asunto(s)
Antiinflamatorios/farmacología , Citocinas/metabolismo , Fármacos Dermatológicos/farmacología , Eosina Amarillenta-(YS)/farmacología , Mediadores de Inflamación/metabolismo , Queratinocitos/efectos de los fármacos , Psoriasis/tratamiento farmacológico , Administración Tópica , Antiinflamatorios/administración & dosificación , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Citocinas/genética , Fármacos Dermatológicos/administración & dosificación , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Ensayo de Inmunoadsorción Enzimática , Eosina Amarillenta-(YS)/administración & dosificación , Humanos , Interferón gamma/metabolismo , Interleucinas/metabolismo , Queratinocitos/inmunología , Psoriasis/inmunología , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/metabolismo
14.
J Dermatolog Treat ; 19(3): 134-40, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18569269

RESUMEN

BACKGROUND: Psoriasis requires lifelong treatments that depend on the extent, clinical forms and associated conditions. OBJECTIVE: To retrospectively analyze which topical treatments were used, their efficacy, and potential advantages and disadvantages. METHODS: A total of 666 patients admitted for the first time over 15 years who were topically treated were retrospectively reviewed and subdivided using clinical forms and PASI into four groups and four subgroups for the applied treatments. For each treatment the mean PASI was calculated daily: on the first, third and sixth day. An X sample statistical analysis and Mann--Whitney U-test were performed. The hospitalization time and correlation with the response to treatment were analyzed. RESULTS: A statistically significant response was recorded for every regimen. The best combination was clobetasol propionate plus eosin on alternate days with eosin plus cade oil. The highest score was recorded for the 'en plaques' psoriasis. The average length of treatment was of 7.5 days in the best combination. No statistically significant difference among the groups was recorded with respect to the length of hospitalization and PASI. CONCLUSION: The statistically significant response for all the topical treatments analyzed and recorded in this study does not exclude a potential benefit due to hospitalization per se.


Asunto(s)
Antiinflamatorios/administración & dosificación , Fármacos Dermatológicos/administración & dosificación , Psoriasis/tratamiento farmacológico , Administración Cutánea , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Calcitriol/administración & dosificación , Calcitriol/análogos & derivados , Clobetasol/administración & dosificación , Quimioterapia Combinada , Eosina Amarillenta-(YS)/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Extractos Vegetales/administración & dosificación , Psoriasis/patología , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Piel/patología , Estadísticas no Paramétricas , Resultado del Tratamiento
16.
Arch Inst Pasteur Tunis ; 76(1-4): 13-8, 1999.
Artículo en Francés | MEDLINE | ID: mdl-14666752

RESUMEN

A randomized placebo-controlled trial treating cutaneous lesions due to Leishmania major with intralesionnel glucantime, was conducted in El Guettar between december 1994 and June 1995, in order to assess efficacy of this therapy under field conditions. It included 109 patients: 52 were administrated glucantime and 57 received local treatment (eosin 5% and alcohol 95%). Prognostic factors were similar in both groups. Results did not reveal a significant difference between glucantime and eosin regarding the rapidity of the healing of lesions. However, scars seem to be of better quality among the glucantime group. Bacterial super infection was noticed among 57.6% of humid lesions sampled among 33 patients. Isolated strains included group A streptococcus (22%), staphylococcus aureus (16.7%) or an association of both agents (61.1%). Resistance profile indicated that streptococcus and staphylococcus respond well to macrolids compared to other antibiotic groups.


Asunto(s)
Antiprotozoarios/administración & dosificación , Leishmania major , Leishmaniasis Cutánea/tratamiento farmacológico , Meglumina/administración & dosificación , Compuestos Organometálicos/administración & dosificación , Zoonosis , Animales , Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana , Eosina Amarillenta-(YS)/administración & dosificación , Femenino , Humanos , Inyecciones Intralesiones , Leishmaniasis Cutánea/complicaciones , Leishmaniasis Cutánea/parasitología , Masculino , Antimoniato de Meglumina , Atención Primaria de Salud , Pronóstico , Método Simple Ciego , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/parasitología , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/parasitología , Streptococcus pyogenes , Sobreinfección/tratamiento farmacológico , Sobreinfección/microbiología , Sobreinfección/parasitología , Resultado del Tratamiento , Túnez , Zoonosis/parasitología
17.
GEN ; 52(1): 15-8, ene.-mar. 1998. tab
Artículo en Español | LILACS | ID: lil-259166

RESUMEN

El propósito de este estudio es comparar una prueba rápida de ureasa (PRUtest) elaborada en el servicio de gastroenterología del Hospital Universitario de Maracaibo, con CLOtest. Usando como Gold Standard para el diagnóstico de infección por H.pylori, histología con Giemsa. Se incluyeron 60 pacientes a quienes se le practicó endoscopia digestiva superior con toma de 4 biopsias a nivel de curvatura mayor de antro, cerca del píloro. Dos biopsias antrales fueron destinadas para estudio histológico con Giemsa y Hematoxilina & Eosina, una para CLOtest y una para PRUtest. A través de histología se identifico 33 (55 por ciento) especímenes positivos para H.pylori y 27 (45 por ciento) fueron negativas. Con PRUtest se obtuvo una sensibilidad de 93,93 por ciento y especificidad de 92,59 por ciento sin diferencia estadísticamente significativa con el CLOtest. Se concluye que el PRUtest es un método seguro para el diagnóstico de infección por H.pylori


Asunto(s)
Humanos , Masculino , Femenino , Biopsia , Endoscopía/estadística & datos numéricos , Eosina Amarillenta-(YS)/administración & dosificación , Helicobacter pylori/clasificación , Hematoxilina/administración & dosificación
19.
Rev. odontol. UNESP ; 25(n.esp): 77-85, jan.-dez. 1996. ilus
Artículo en Portugués | LILACS, BBO - Odontología | ID: lil-197494

RESUMEN

A finalidade do nosso trabalho foi observar histologicamente alteraçöes que ocorreram na mucosa oral, resultantes do uso das próteses totais mucossuportadas. Para tanto, foram selecionados dez pacientes portadores de prótese total mucossuportada, nos quais a mucosa oral, que seria a regiäo de suporte, apresentasse, simultaneamente, áreas consideradas clinicamente sadias, com leves alteraçöes severas. Foram realizadas três biópsias em cada paciente, cada uma correspondendo às áreas previamente referidas, e esse material foi submetido à técnica de preparo histológico de rotina. Os cortes foram corados por hematoxilina e eosina. Baseados nos resultados histopatológicos, foi-nos lícito concluir que o fato de o paciente utilizar prótese total mucossuportada pode induzir a algum tipo de alteraçäo histofisiológica da mucosa oral. Por sua vez, a existência de fatores irritantes locais pode, do mesmo modo, levar a mucosa oral a profundas alteraçöes em nível tanto epitelial quanto conjuntivo


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Mucosa Bucal/anomalías , Prótesis Dental , Eosina Amarillenta-(YS)/administración & dosificación , Eosina Amarillenta-(YS)/análisis , Hematoxilina/administración & dosificación , Hematoxilina/análisis
20.
C R Acad Sci III ; 319(11): 991-6, 1996 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9064122

RESUMEN

This study focuses on the use of hematoxylin-eosin staining plus fluorescence microscopy for the investigation of elastic fibers in some elastic cartilages. We have observed that elastic fibers are consistently imaged by the proposed procedure and the resolution attained is similar to that obtained with the classical Weigert's fuchsin-resorcin. The results also demonstrate that elastin autofluorescence gives little or no contribution to the final fluorescence and that the use of the confocal laser scanning microscope adds to the resolution, permits the use of thicker sections and reveals of minute structural at features. We conclude that this is a relevant tool in elastin research.


Asunto(s)
Tejido Elástico/ultraestructura , Eosina Amarillenta-(YS) , Colorantes Fluorescentes , Hematoxilina , Colorantes de Rosanilina , Animales , Cartílago/ultraestructura , Perros , Eosina Amarillenta-(YS)/administración & dosificación , Colorantes Fluorescentes/administración & dosificación , Hematoxilina/administración & dosificación , Microscopía Confocal/métodos , Microscopía Fluorescente/métodos , Resorcinoles/administración & dosificación , Colorantes de Rosanilina/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...